|
Name |
Tiglic acid
|
Molecular Formula | C5H8O2 | |
IUPAC Name* |
(E)-2-methylbut-2-enoic acid
|
|
SMILES |
C/C=C(\C)/C(=O)O
|
|
InChI |
InChI=1S/C5H8O2/c1-3-4(2)5(6)7/h3H,1-2H3,(H,6,7)/b4-3+
|
|
InChIKey |
UIERETOOQGIECD-ONEGZZNKSA-N
|
|
Synonyms |
TIGLIC ACID; 80-59-1; Tiglinic acid; Cevadic acid; 2-methylbut-2-enoic acid; trans-2,3-Dimethylacrylic acid; (E)-2-Methylbut-2-enoic acid; 2-Methyl-2-butenoic acid; trans-2-Methylcrotonic acid; trans-2-Methyl-2-butenoic acid; (E)-2,3-Dimethylacrylic acid; (E)-2-Methylcrotonic acid; (E)-2-Methyl-2-butenoic acid; 2-Butenoic acid, 2-methyl-, (2E)-; Crotonic acid, 2-methyl-, (E)-; tiglate; alpha-Methylcrotonic acid; 2-Butenoic acid, 2-methyl-, (E)-; (2E)-2-methylbut-2-enoic acid; 2,3-Dimethylacrylic acid, (E)-; 2-Methylcrotonic acid; trans-alpha,beta-Dimethylacrylic acid; FEMA No. 3599; 13201-46-2; NSC 44235; (E)-2-methyl-Crotonic acid; 2,3-Dimethylacrylic acid; 2-methyl-2E-butenoic acid; Tiglicacid; trans-.alpha.,.beta.-Dimethylacrylic acid; CHEBI:9592; 2-methyl-(E)-2-butenoic acid; alpha,beta-dimethyl acrylic acid; NSC8999; I5792N03HC; NSC-8999; NSC44235; NSC-44235; sabadillic acid; methyl methacrylic acid; alpha-Methylcrotonic acid, (E)-; 2-Methyl-2-butenoic acid, (E)-; EINECS 201-295-0; MFCD00066864; BRN 1236500; Tiglinsaeure; Cevadate; Tiglinate; epsilon-Tiglate; UNII-I5792N03HC; AI3-36118; E-Tiglate; Methylbutenoicacid; E-Tiglic acid; HSDB 7614; (2E)-2-Methyl-2-butenoic acid; (E)-tiglic acid; 2-methyl-Crotonate; epsilon-Tiglic acid; EINECS 236-167-3; methyl crotonic acid; methylmethacrylic acid; 2,3-Dimethylacrylate; 2-methyl-2-butenoate; Tiglic acid, (E)-; 2-Methylbut-2-enoate; 2-methyl-Crotonic acid; trans-2-Methylcrotonate; (E)-2-Methylcrotonate; 2-methylbut-2-enoicacid; (E)-2-methyl-Crotonate; alpha-methyl-crotonic acid; TIGLIC ACID [MI]; bmse000727; TIGLIC ACID [HSDB]; trans-2,3-Dimethylacrylate; (E)-2,3-Dimethylacrylate; 2-Butenoic acid,2-methyl-; 2-methyl-(E)-2-butenoate; trans-2-Methyl-2-butenoate; (E)-2-methyl-2-Butenoate; SCHEMBL15042; 4-02-00-01552 (Beilstein Handbook Reference); CHEMBL52416; (2E)-2-Methyl-2-butenoate; GTPL6499; trans-Crotonic acid, 2-methyl-; CHEBI:36432; trans-alpha,beta-Dimethylacrylate; DTXSID80883257; E)-2-METHYLCROTONIC ACID; trans-2-methyl-but-2-enoic acid; ZINC897443; BCP18945; (2E)-2-Methyl-2-butenoic acid #; LMFA01020030; s3789; AKOS003375681; CCG-266028; CS-W013715; HY-W012999; trans-2,3-Dimethylacrylic acid, 98%; (E)-.ALPHA.-METHYLCROTONIC ACID; LS-13047; 2-METHYLBUT-2-ENOIC ACID, (E)-; METHYL-2-BUTENOIC ACID, TRANS-2-; CS-0356606; T0246; EN300-83150; C08279; EN300-370249; TRANS-2-METHYL-2-BUTENOIC ACID [FHFI]; trans-2-Methyl-2-butenoic acid, >=99%, FG; A839954; Q425475; Q27116830; F0001-2086; trans-2-Methylcrotonic acid = trans-2-Methyl-2-butenoate; trans-2-Methylcrotonic acid = trans-2-Methyl-2-butenoic acid; trans-2-Methylcrotonic acid = trans-2-Methyl-2-butenoic acid = Tiglinate; alpha,beta-dimethyl acrylic acid; 2-Methyl-2-butenoic acid; (E)-2-methyl-Crotonic acid; trans-2-Methylcrotonic acid = trans-2-Methyl-2-butenoic acid = Tiglinic acid
|
|
CAS | 80-59-1 | |
PubChem CID | 125468 | |
ChEMBL ID | CHEMBL52416 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 100.12 | ALogp: | 1.0 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 7 | QED Weighted: | 0.507 |
Caco-2 Permeability: | -4.588 | MDCK Permeability: | 0.00002670 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.04 |
Blood-Brain-Barrier Penetration (BBB): | 0.544 | Plasma Protein Binding (PPB): | 33.31% |
Volume Distribution (VD): | 0.317 | Fu: | 67.87% |
CYP1A2-inhibitor: | 0.046 | CYP1A2-substrate: | 0.471 |
CYP2C19-inhibitor: | 0.051 | CYP2C19-substrate: | 0.072 |
CYP2C9-inhibitor: | 0.054 | CYP2C9-substrate: | 0.317 |
CYP2D6-inhibitor: | 0.028 | CYP2D6-substrate: | 0.187 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.074 |
Clearance (CL): | 5.154 | Half-life (T1/2): | 0.897 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.271 |
Drug-inuced Liver Injury (DILI): | 0.185 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.41 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.503 | Carcinogencity: | 0.126 |
Eye Corrosion: | 0.968 | Eye Irritation: | 0.996 |
Respiratory Toxicity: | 0.046 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001585 | 0.481 | D0G4JI | 0.429 | ||||
ENC000061 | 0.429 | D04CRL | 0.389 | ||||
ENC001556 | 0.429 | D0R9BG | 0.273 | ||||
ENC000009 | 0.389 | D0Z4NI | 0.259 | ||||
ENC001629 | 0.333 | D0F1GS | 0.259 | ||||
ENC001727 | 0.323 | D09PUL | 0.250 | ||||
ENC000313 | 0.308 | D08QGD | 0.240 | ||||
ENC000149 | 0.304 | D0Z4UY | 0.238 | ||||
ENC000010 | 0.304 | D0C1PY | 0.238 | ||||
ENC000001 | 0.300 | D02FLB | 0.238 |